| 1 |
Dilliard SA, Siegwart DJ. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat Rev Mater 2023;:1-19. [PMID: 36691401 DOI: 10.1038/s41578-022-00529-7] [Reference Citation Analysis]
|
| 2 |
Xu Q, Chen Y, Jin Y, Wang Z, Dong H, Kaufmann AM, Albers AE, Qian X. Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer. Viruses 2022;14. [PMID: 36560828 DOI: 10.3390/v14122824] [Reference Citation Analysis]
|
| 3 |
Gabel M, Knauss A, Fischer D, Neurath MF, Weigmann B. Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies. Int J Mol Sci 2022;23. [PMID: 36430411 DOI: 10.3390/ijms232213929] [Reference Citation Analysis]
|
| 4 |
Nantajit D, Presta L, Sauter T, Tavassoli M. EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma. Cell Death Dis 2022;13:921. [PMID: 36333293 DOI: 10.1038/s41419-022-05269-8] [Reference Citation Analysis]
|
| 5 |
Wu SY, Wu FG, Chen X. Antibody-Incorporated Nanomedicines for Cancer Therapy. Adv Mater 2022;:e2109210. [PMID: 35142395 DOI: 10.1002/adma.202109210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 6 |
Swart LE, Koekman CA, Seinen CW, Issa H, Rasouli M, Schiffelers RM, Heidenreich O. A Robust Post-Insertion Method for the Preparation of Targeted siRNA LNPs. Int J Pharm 2022;:121741. [PMID: 35421533 DOI: 10.1016/j.ijpharm.2022.121741] [Reference Citation Analysis]
|
| 7 |
Pandey PR, Young KH, Kumar D, Jain N. RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01528-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 8 |
Salinas-Montalvo AM, Supramaniam A, McMillan NA, Idris A. RNA-based gene targeting therapies for human papillomavirus driven cancers. Cancer Lett 2021;523:111-20. [PMID: 34627949 DOI: 10.1016/j.canlet.2021.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 9 |
Pan L, Li B, Chen J, Zhang H, Wang X, Shou J, Yang D, Yan X. Nanotechnology-Based Weapons to Combat Human Papillomavirus Infection Associated Diseases. Front Chem 2021;9:798727. [PMID: 34869242 DOI: 10.3389/fchem.2021.798727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
